Physician profile
Thomas Lee
NPI 1063405868
$3,973,351.38
in general payments reported to CMS, 2019-2025
9 companies · $14.41 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843K · 2020: $722K · 2021: $541K · 2022: $1.5M · 2023: $304K · 2024: $71K · 2025: $14.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $248K · Consulting Fee: $67K · Travel and Lodging: $40K · Food and Beverage: $21K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $247,608.21 |
| Consulting Fee | $66,690.36 |
| Travel and Lodging | $39,685.55 |
| Food and Beverage | $21,138.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,344,286.79 | 2019-2025 | Claw II, Ortholoc 3di, Asnis |
| Wright Medical Technology, INC. | $1,302,809.29 | 2019-2020 | |
| Novastep INC. | $727,486.72 | 2021-2023 | Apollo Ankle Fracture Plating System, Arcad Nitinol Compression Staples, Creed Ortholocent Implants |
| Glw, INC | $598,153.39 | 2022 | |
| Royal Biologics, INC. | $377.36 | 2020 | |
| Medshape, INC. | $129.36 | 2023 | |
| Zimmer Biomet Holdings, INC. | $47.89 | 2023 | Dvr Anatomic Kickstand |
| Paragon 28, INC. | $36.25 | 2023 | Portfolio |
| Depuy Synthes Sales INC. | $24.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.